These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A postmortem study of amino acid neurotransmitters in Alzheimer's disease. Ellison DW; Beal MF; Mazurek MF; Bird ED; Martin JB Ann Neurol; 1986 Nov; 20(5):616-21. PubMed ID: 2878639 [TBL] [Abstract][Full Text] [Related]
23. Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models. Van Dam D; Marescau B; Engelborghs S; Cremers T; Mulder J; Staufenbiel M; De Deyn PP Neurochem Int; 2005 Apr; 46(5):409-22. PubMed ID: 15737439 [TBL] [Abstract][Full Text] [Related]
24. [Dementia and Parkinson's disease: biochemical and anatomo-clinical correlation]. Dubois B; Hauw JJ; Ruberg M; Serdaru M; Javoy-Agid F; Agid Y Rev Neurol (Paris); 1985; 141(3):184-93. PubMed ID: 4001706 [TBL] [Abstract][Full Text] [Related]
25. Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment. Francis PT; Palmer AM; Sims NR; Bowen DM; Davison AN; Esiri MM; Neary D; Snowden JS; Wilcock GK N Engl J Med; 1985 Jul; 313(1):7-11. PubMed ID: 2582256 [TBL] [Abstract][Full Text] [Related]
26. Tau antisera recognize neurofibrillary tangles in a range of neurodegenerative disorders. Joachim CL; Morris JH; Kosik KS; Selkoe DJ Ann Neurol; 1987 Oct; 22(4):514-20. PubMed ID: 2963585 [TBL] [Abstract][Full Text] [Related]
27. Neuropathological correlates of memory dysfunction in the Wernicke-Korsakoff syndrome. Halliday G; Cullen K; Harding A Alcohol Alcohol Suppl; 1994; 2():245-51. PubMed ID: 8974343 [TBL] [Abstract][Full Text] [Related]
28. [Alterations in neurotransmitter in multi-infarct dementia and senile dementia of alzheimer's type (author's transl)]. Miyata S; Yamao S; Nakamura S; Udaka F; Kameyama M Rinsho Shinkeigaku; 1981 Jun; 21(6):491-7. PubMed ID: 6117387 [No Abstract] [Full Text] [Related]
30. Neurotransmitters and neuropeptides in Alzheimer's disease. McDonald WM; Nemeroff CB Psychiatr Clin North Am; 1991 Jun; 14(2):421-42. PubMed ID: 1676509 [TBL] [Abstract][Full Text] [Related]
31. Neurochemical basis of dementia in Parkinson's disease. Hornykiewicz O; Kish SJ Can J Neurol Sci; 1984 Feb; 11(1 Suppl):185-90. PubMed ID: 6143610 [TBL] [Abstract][Full Text] [Related]
32. Possible neurotransmitter basis of behavioral changes in Alzheimer's disease. Palmer AM; Stratmann GC; Procter AW; Bowen DM Ann Neurol; 1988 Jun; 23(6):616-20. PubMed ID: 2457353 [TBL] [Abstract][Full Text] [Related]
33. [Preliminary research on multi-neurotransmitters' change regulation in 120 depression patients' brains]. Chi M; Qing XM; Pan YS; Xu FQ; Liu C; Zhang C; Xu ZH Zhongguo Zhong Yao Za Zhi; 2014 Apr; 39(8):1516-24. PubMed ID: 25039193 [TBL] [Abstract][Full Text] [Related]
34. Studies on neurotransmitter binding in senile dementia. Comparison of Alzheimer's and mixed vascular-Alzheimer's dementias. Jenni-Eiermann S; von Hahn HP; Honegger CG; Ulrich J Gerontology; 1984; 30(6):350-8. PubMed ID: 6151534 [TBL] [Abstract][Full Text] [Related]
35. Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and Down's syndrome. Yates CM; Simpson J; Gordon A; Maloney AF; Allison Y; Ritchie IM; Urquhart A Brain Res; 1983 Nov; 280(1):119-26. PubMed ID: 6228286 [TBL] [Abstract][Full Text] [Related]
36. Alzheimer's disease and senile dementia: biochemical characteristics and aspects of treatment. Gottfries CG Psychopharmacology (Berl); 1985; 86(3):245-52. PubMed ID: 2863836 [TBL] [Abstract][Full Text] [Related]
37. Non-cholinergic neurotransmitter abnormalities in Alzheimer's disease. Rossor M; Iversen LL Br Med Bull; 1986 Jan; 42(1):70-4. PubMed ID: 2869818 [No Abstract] [Full Text] [Related]